IRIS Accounts Production v23.1.5.20 11890460 director 1.4.22 31.3.23 31.3.23 0 0 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh118904602022-03-31118904602023-03-31118904602022-04-012023-03-31118904602021-03-31118904602021-04-012022-03-31118904602022-03-3111890460ns15:EnglandWales2022-04-012023-03-3111890460ns14:PoundSterling2022-04-012023-03-3111890460ns10:Director12022-04-012023-03-3111890460ns10:PrivateLimitedCompanyLtd2022-04-012023-03-3111890460ns10:SmallEntities2022-04-012023-03-3111890460ns10:AuditExempt-NoAccountantsReport2022-04-012023-03-3111890460ns10:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3111890460ns10:SmallCompaniesRegimeForAccounts2022-04-012023-03-3111890460ns10:FullAccounts2022-04-012023-03-3111890460ns10:OrdinaryShareClass12022-04-012023-03-3111890460ns10:CompanySecretary12022-04-012023-03-3111890460ns10:RegisteredOffice2022-04-012023-03-3111890460ns5:CurrentFinancialInstruments2023-03-3111890460ns5:CurrentFinancialInstruments2022-03-3111890460ns5:ShareCapital2023-03-3111890460ns5:ShareCapital2022-03-3111890460ns5:RetainedEarningsAccumulatedLosses2023-03-3111890460ns5:RetainedEarningsAccumulatedLosses2022-03-3111890460ns5:PlantMachinery2022-04-012023-03-3111890460ns5:PlantMachinery2023-03-3111890460ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3111890460ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-03-3111890460ns10:OrdinaryShareClass12023-03-31
REGISTERED NUMBER: 11890460 (England and Wales)














FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2023

FOR

LYMPH SOLUTIONS LTD

LYMPH SOLUTIONS LTD (REGISTERED NUMBER: 11890460)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


LYMPH SOLUTIONS LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2023







DIRECTOR: J L Everett





SECRETARY: J H Everett





REGISTERED OFFICE: 6 Fellside Gardens
Belmont
Durham
DH1 1AB





REGISTERED NUMBER: 11890460 (England and Wales)





ACCOUNTANTS: Ribchesters
Chartered Accountants
Finchale House
Belmont Business Park
Durham
DH1 1TW

LYMPH SOLUTIONS LTD (REGISTERED NUMBER: 11890460)

BALANCE SHEET
31 MARCH 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 833 -

CURRENT ASSETS
Debtors 5 1,162 4,857
Cash at bank 20,994 25,688
22,156 30,545
CREDITORS
Amounts falling due within one year 6 11,369 18,115
NET CURRENT ASSETS 10,787 12,430
TOTAL ASSETS LESS CURRENT
LIABILITIES

11,620

12,430

PROVISIONS FOR LIABILITIES 208 -
NET ASSETS 11,412 12,430

CAPITAL AND RESERVES
Called up share capital 7 2 2
Retained earnings 11,410 12,428
SHAREHOLDERS' FUNDS 11,412 12,430

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 26 October 2023 and were signed by:



J L Everett - Director


LYMPH SOLUTIONS LTD (REGISTERED NUMBER: 11890460)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

1. STATUTORY INFORMATION

Lymph Solutions Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Equipment - 20% on cost.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2022 - NIL).

LYMPH SOLUTIONS LTD (REGISTERED NUMBER: 11890460)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2023

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
Additions 1,000
At 31 March 2023 1,000
DEPRECIATION
Charge for year 167
At 31 March 2023 167
NET BOOK VALUE
At 31 March 2023 833

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 1,145 4,775
Other debtors 17 82
1,162 4,857

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Taxation and social security 1,890 3,587
Other creditors 9,479 14,528
11,369 18,115

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
2 Ordinary £1 2 2

8. RELATED PARTY DISCLOSURES

During the period the director provided the company with an interest free loan. At 31 March 2023 the balance of this loan was £170 (2022: £12,308).

During the period the company secretary charged the company for various services rendered amounting to£9,500 (2022: £10,000). The director confirms that arrangements were on third party terms.